NASDAQ · Price History

Turn Therapeutics Inc. (TTRX) Stock Price History & Returns

$8.55 NASDAQ: TTRX Market Cap $261.40M

Price history through Nov 16, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Turn Therapeutics Inc. (TTRX) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $8.55 sits 43% of the way up a 52-week range of $2.57 to $16.45; 48.0% below the 52-week high; a beta of 2.04 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-12.9%
6 months+72.0%
1 year+144.3%

Year by year

1 of 1 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$8.55+117.0%

Monthly closing prices

The last 14 months, newest first. 8 of 13 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$8.55-18.0%
October 2026$10.43-27.5%
September 2026$14.39+49.9%
August 2026$9.60+14.8%
July 2026$8.36+14.5%
June 2026$7.30+40.4%
May 2026$5.20+40.9%
April 2026$3.69+15.3%
March 2026$3.20-11.1%
February 2026$3.60-12.6%
January 2026$4.12+4.6%
December 2025$3.94+11.9%
November 2025$3.52-27.4%
October 2025$4.85—

Turn Therapeutics Inc. (TTRX) price history — frequently asked questions

How has Turn Therapeutics Inc. performed over the last year?

Turn Therapeutics Inc. (TTRX) has risen 144.3% over the last twelve months, measured on price alone.

What is Turn Therapeutics Inc.'s five-year return?

Over five years the TTRX share price has gained 0.0%, excluding dividends.

What is Turn Therapeutics Inc.'s 52-week range?

Over the last year Turn Therapeutics Inc. (TTRX) has traded between $2.57 and $16.45.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.